Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Scott Daniels

Showing results (21-30 of 122) with videos related to

Pageof 13
Sort By:
JAMA Network Open|January 16, 2019
Assessment of Patient Medication Adherence, Medical Record Accuracy, and Medication Blood Concentrations for Prescription and Over-the-Counter MedicationsJeffrey J Sutherland, Ryan D Morrison, Candace D McNaughton, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 13, 2015
A Screen of Approved Drugs Identifies the Androgen Receptor Antagonist Flutamide and Its Pharmacologically Active Metabolite 2-Hydroxy-Flutamide as Heterotropic Activators of Cytochrome P450 3A In Vitro and In VivoAnna L Blobaum, Frank W Byers, Thomas M Bridges, et al.
Journal of Pharmaceutical Sciences|March 16, 2010
Utilizing a novel tandem oral dosing strategy to enhance exposure of low-solubility drug candidates in a preclinical settingPo-Chang Chiang, Sarah A South, Kimberly A Foster, et al.
Chemical Research in Toxicology|March 16, 2013
Enzymatic conversion of 6-nitroquinoline to the fluorophore 6-aminoquinoline selectively under hypoxic conditionsAnuruddha Rajapakse, Collette Linder, Ryan D Morrison, et al.
Bioorganic & Medicinal Chemistry Letters|December 11, 2012
Development of an in vivo active, dual EP1 and EP3 selective antagonist based on a novel acyl sulfonamide bioisostereJason D Downey, Sam A Saleh, Thomas M Bridges, et al.
ACS Chemical Neuroscience|September 7, 2016
Lack of Antiparkinsonian Effects of Systemic Injections of the Specific T-Type Calcium Channel Blocker ML218 in MPTP-Treated MonkeysAdriana Galvan, Annaelle Devergnas, Damien Pittard, et al.
Bioorganic & Medicinal Chemistry Letters|June 26, 2012
Further optimization of the K-Cl cotransporter KCC2 antagonist ML077: development of a highly selective and more potent in vitro probeEric Delpire, Aleksandra Baranczak, Alex G Waterson, et al.
Journal of Pharmaceutical Sciences|May 2, 2008
Aqueous versus non-aqueous salt delivery strategies to enhance oral bioavailability of a mitogen-activated protein kinase-activated protein kinase (MK-2) inhibitor in ratsPo-Chang Chiang, Sarah A South, J Scott Daniels, et al.
Bioorganic & Medicinal Chemistry Letters|August 25, 2015
Optimization of a small molecule probe that restores e-cadherin expressionJohn T Brogan, Sydney L Stoops, Suzanne Brady, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 15, 2006
In vivo oxidative metabolism of a major peroxidation-derived DNA adduct, M1dGMichael B Otteneder, Charles G Knutson, J Scott Daniels, et al.
Pageof 13

Showing results (21-30 of 122) with videos related to

Sort By:
Pageof 13
JAMA Network Open|January 16, 2019
Assessment of Patient Medication Adherence, Medical Record Accuracy, and Medication Blood Concentrations for Prescription and Over-the-Counter MedicationsJeffrey J Sutherland, Ryan D Morrison, Candace D McNaughton, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 13, 2015
A Screen of Approved Drugs Identifies the Androgen Receptor Antagonist Flutamide and Its Pharmacologically Active Metabolite 2-Hydroxy-Flutamide as Heterotropic Activators of Cytochrome P450 3A In Vitro and In VivoAnna L Blobaum, Frank W Byers, Thomas M Bridges, et al.
Journal of Pharmaceutical Sciences|March 16, 2010
Utilizing a novel tandem oral dosing strategy to enhance exposure of low-solubility drug candidates in a preclinical settingPo-Chang Chiang, Sarah A South, Kimberly A Foster, et al.
Chemical Research in Toxicology|March 16, 2013
Enzymatic conversion of 6-nitroquinoline to the fluorophore 6-aminoquinoline selectively under hypoxic conditionsAnuruddha Rajapakse, Collette Linder, Ryan D Morrison, et al.
Bioorganic & Medicinal Chemistry Letters|December 11, 2012
Development of an in vivo active, dual EP1 and EP3 selective antagonist based on a novel acyl sulfonamide bioisostereJason D Downey, Sam A Saleh, Thomas M Bridges, et al.
ACS Chemical Neuroscience|September 7, 2016
Lack of Antiparkinsonian Effects of Systemic Injections of the Specific T-Type Calcium Channel Blocker ML218 in MPTP-Treated MonkeysAdriana Galvan, Annaelle Devergnas, Damien Pittard, et al.
Bioorganic & Medicinal Chemistry Letters|June 26, 2012
Further optimization of the K-Cl cotransporter KCC2 antagonist ML077: development of a highly selective and more potent in vitro probeEric Delpire, Aleksandra Baranczak, Alex G Waterson, et al.
Journal of Pharmaceutical Sciences|May 2, 2008
Aqueous versus non-aqueous salt delivery strategies to enhance oral bioavailability of a mitogen-activated protein kinase-activated protein kinase (MK-2) inhibitor in ratsPo-Chang Chiang, Sarah A South, J Scott Daniels, et al.
Bioorganic & Medicinal Chemistry Letters|August 25, 2015
Optimization of a small molecule probe that restores e-cadherin expressionJohn T Brogan, Sydney L Stoops, Suzanne Brady, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 15, 2006
In vivo oxidative metabolism of a major peroxidation-derived DNA adduct, M1dGMichael B Otteneder, Charles G Knutson, J Scott Daniels, et al.
Pageof 13